3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
5
Thoracic
1
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Colorectal Neoplasms
105
Carcinoma, Hepatocellular
34
Gastrointestinal Stromal Tumors
17
Colonic Neoplasms
14
Rectal Neoplasms
12
Neoplasm Metastasis
12
Liver Neoplasms
8
Stomach Neoplasms
5
Cholangiocarcinoma
5
Pancreatic Neoplasms
4
Esophageal Neoplasms
4
Sarcoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Colorectal Cancer Metastatic
3
Carcinoma, Renal Cell
3
Advanced Colorectal Cancer
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Lung Neoplasms
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Fatigue
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Cancer Liver Metastases
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
pembrolizumab
50
Cyclophosphamide
25
Carboplatin
25
Gemcitabine
20
Cisplatin
19
fludarabine
18
Nivolumab
17
Paclitaxel
16
Bevacizumab
15
Specimen Handling
14
Fluorouracil
11
Magnetic Resonance Spectroscopy
10
aldesleukin
9
Oxaliplatin
9
Irinotecan
9
Docetaxel
9
Biopsy
9
olaparib
8
Trastuzumab
8
durvalumab
7
atezolizumab
7
Hyperthermic Intraperitoneal Chemotherapy
7
Albumin-Bound Paclitaxel
7
Taxes
6
Leucovorin
6
Ipilimumab
6
Interleukin-2
6
Cetuximab
6
Capecitabine
6
130-nm albumin-bound paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
regorafenib
×
Gastrointestinal
×
Clear all
NCT02307500
2022-09-10
RESOUND
Istituto Clinico Humanitas
Phase 2
Completed
82 enrolled